Caribou has initiated the GALLOP Phase 1 clinical trial, an open-label, multicenter clinical trial designed to evaluate a single infusion of CB-010 in adult patients with LN and ERL. CB-011, a ...

Exagen Inc. (XGN), a provider of autoimmune testing, said that it has received conditional approval from the New York State ...

New research reveals how social determinants of health significantly affect lupus treatment outcomes in Black patients, with 80% facing critical healthcare barriers.

Study finds lupus patients face a doubled risk of cervical artery dissection, highlighting the need for vigilant ...

The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Northern District of California on behalf of those who acquired ...

IGM Biosciences announced the discontinuation of imvotamab and IGM-2644 for autoimmune and inflammatory diseases, including ...

Patients with SLE have a higher prevalence of primary headaches vs those with RA or pSS, but similar percentages were found when comparing healthy controls.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

In a new study published in Lupus Science & Medicine, researchers reviewed randomized clinical trials (RCTs) to assess ...

A German research team’s discoveries about autoimmune diseases are opening up new possibilities for patients with lupus and ...

We described the first case reported in the literature of multiple myeloma in a young African woman with Systemic lupus and Sjögren Syndrome. The clinician should consider multiple myeloma in young ...

OKLAHOMA CITY — Scientists at the Oklahoma Medical Research Foundation are one step closer to determining the genetic trigger for lupus in some people. Over two years of experiments, Swapan Nath ...